Data Science in Pharmaceutical Development

Vivek P. Chavda, PhD is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, Lallubhai Motilal College of Pharmacy, Ahmedabad, India. He has over 100 national and international publications, 30 book chapters, ten books, and two patents to his credit. His research interests include the development of biologics processes and formulations, medical device development, nanodiagnostics and non-carrier formulations, long-acting parenteral formulations, and nano-vaccines. Usha Desai, PhD is a professor and the Dean of Research and Development at the South East Asia College of Engineering and Technology, Bangalore, India. She authored over 50 research articles, five books, and six patents, and has presented technical research papers in numerous international conferences. Her research interests include biomedical signal processing, machine learning, and brain-computer interface.

• Foreword xixPreface xxiPart 1: Fundamentals of Data Science in Pharmaceuticals 11 Introduction to AI in Medicine and Drug Delivery 3Dixa A. Vaghela, Pankti C. Balar and Vivek P. Chavda1.1 Introduction 31.2 Applications of AI in Medicine 41.2.1 AI in Drug Discovery 51.2.1.1 Target Identification 51.2.1.2 Compound Selection 51.2.1.3 Predictive Modeling in Drug Discovery 51.2.2 Personalized Medicine 61.2.2.1 Tailoring Treatments 61.2.2.2 Genetic and Lifestyle Consideration 61.2.3 Advanced AI Techniques in Medicine 71.2.3.1 Medical Imaging and Diagnostic 71.2.3.2 Patient Monitoring and Remote Care 71.2.3.3 Surgical Assistance and Robotics 71.3 AI in Drug Delivery Systems 81.3.1 Smart Drug Delivery Networks 81.3.2 Nanotechnology-Based Drug Delivery 91.4 Future Trends and Ethical Considerations 101.5 Conclusion 12References 142 Data Visualization in Pharmaceutical Development 19Gagandeep Kaur, Benu Chaudhary, Vikas Sharma, Parul Sood and Rupesh K. Gautam2.1 Introduction 202.2 Digitalization of a Continuous Process Manufacturing for Formulated Products 212.2.1 Data Visualization and Cloud Integration 212.3 Clinical Trial Data Visualization 222.4 Decision Making in Product Portfolios of Pharmaceutical Research and Development—Managing Streams of Innovation in Highly Regulated Markets 242.5 Genomic Data Visualization 242.5.1 Opportunities and Challenges 252.6 Real-World Evidence (RWE) Research 292.7 Pharmacokinetic/Pharmacodynamic (PK/PD) Indices 312.8 Supply Chain Visualization 322.9 Designing Medical Data Visualizations 322.10 Pharmacovigilance: Data Visualization 332.11 Health Econometric: Data Visualization 352.12 Explainable Artificial Intelligence: Visualizing 372.13 Conclusion 39References 393 Data Science and AI for Transforming R&D 47Parul Sood, Gagandeep Kaur, Jatin Kumar, Narinderpal Kaur, Nitin Jangra and Rupesh K. Gautam3.1 Introduction 483.2 Artificial Intelligence and Machine Learning 493.3 Data Science and AI for Transforming R&D 503.4 Machine Learning and AI Approaches in Drug Discovery 513.4.1 Target Selection and Validation 513.4.2 Drug Design 523.4.3 ADMET Modeling 523.5 Methods for Improving Existing Approaches in R&D 533.5.1 Deep Learning for Protein Structure Prediction and Drug Repurposing 553.5.2 AI in Advancing Pharmaceutical Product Development 563.5.3 Machine Learning/AI for Developing Predictive Biomarkers 573.5.4 AI in Product Cost 573.5.5 AI Emergence in Nanomedicine 583.5.6 AI/ML for Precision Medicine 583.5.7 AI/ML in Quality Control and Quality Assurance 593.5.8 AI/ML-Assisted Tool for Clinical Trial Oversight 603.5.9 AI in Finding the Hit or Lead 613.6 Conclusion 61References 62Part 2: Applications of Data Science in Pharmaceutical Development 674 Applications of Medical IoT and Smart Sensor Paradigm for Handling Patients 69Keshava Jetha, Krupa Vyas, Jalpan Shah, Dhvani Trivedi and Ritul Patel4.1 Introduction to Medical IoT and Smart Sensors 704.2 IoT and Smart Sensor in Chronic Disease Management 714.3 IoT and Smart Sensors in Post-Operative Monitoring 764.4 Applications of Medical IoT and Smart Sensor 784.5 Remote Patient Monitoring 834.6 Enhancing Patient Safety and Ethical Perspective 874.7 Future Directions and Challenges 884.8 Conclusion 91References 925 Predictive Models for Drug Development Using Expert Systems 103Nirmal Joshi, Deepak Chandra Joshi, Suraj Koranga, Kajal Gurow and Mayuri Bapu Chavan5.1 Introduction to Predictive Modeling in Drug Development 1045.1.1 Overview of the Drug Development Process 1045.1.2 Role of Predictive Modeling in Drug Discovery and Development 1055.1.3 Introduction to Expert Systems and Their Applications in Pharmaceutical Research 1055.1.4 Importance of Predictive Models in Accelerating Drug Development Timelines 1075.2 Fundamentals of Expert Systems 1075.2.1 Definition and Characteristics of Expert Systems 1085.2.2 Components of Expert Systems: Knowledge Base, Inference Engine, User Interface 1095.2.3 Types of Expert Systems: Rule-Based, Fuzzy Logic, Bayesian Networks, etc. 1105.2.4 Advantages and Limitations of Expert Systems in Drug Development 1125.2.5 Advantages of Expert Systems in Drug Development 1125.2.6 Limitations of Expert Systems in Drug Development 1125.3 Data Collection and Pre-Processing for Predictive Modeling 1135.3.1 Sources of Data in Drug Development: Clinical Trials, Pre-Clinical Studies, Literature, Databases, etc. 1135.3.2 Data Pre-Processing Techniques: Data Cleaning Feature Selection, Normalization, etc. 1145.3.3 Challenges in Data Collection and Pre-Processing for Predictive Modeling in Drug Development 1145.4 Building Rule-Based Expert Systems for Drug Development 1175.4.1 Principles of Rule-Based Systems 1175.4.2 Knowledge Acquisition: Expert Interviews, Literature Review, and Data Analysis 1185.4.3 Rule Generation and Representation 1195.4.4 Case Studies Illustrating the Development of Rule-Based Expert Systems for Drug Discovery and Development 1215.5 Applications of Fuzzy Logic in Predictive Modeling 1215.5.1 Introduction to Fuzzy Logic and Fuzzy Sets 1215.5.2 Fuzzy Inference Systems for Drug Development 1235.5.3 Case Studies Demonstrating the Application of Fuzzy Logic in Predicting Pharmacokinetic Parameters, Toxicity, etc. 1255.6 Bayesian Networks in Drug Development 1265.6.1 Basics of Bayesian Networks 1265.6.1.1 Applications of Bayesian Networks in Drug Development 1265.6.1.2 Advantages of Utilizing BNs in Pharmaceutical Research 1275.6.2 Bayesian Networks for Predicting Drug-Target Interactions, Drug Efficacy, Adverse Effects, etc. 1275.6.3 Challenges and Opportunities in Using Bayesian Networks for Predictive Modeling in Drug Development 1295.7 Integration of Predictive Models in Drug Development Workflow 1305.7.1 Incorporating Predictive Models into Decision-Making Processes 1305.7.2 Challenges in Integrating Predictive Models with Experimental Data 1325.7.3 Real-World Examples of Successful Integration of Predictive Models in Drug Development Pipelines 1325.8 Validation and Evaluation of Predictive Models 1335.8.1 Importance of Model Validation and Evaluation 1335.8.2 Validation Techniques: Cross-Validation, Bootstrapping, External Validation, etc. 1345.8.2.1 Validation Techniques 1345.8.3 Performance Metrics for Evaluating Predictive Models in Drug Development 1345.8.4 Considerations for Selecting Appropriate Validation Methods Based on the Type of Predictive Model 1355.9 Future Perspectives and Emerging Trends 1365.9.1 Advances in Predictive Modeling Techniques for Drug Development 1365.9.2 Role of Artificial Intelligence and Machine Learning in Enhancing Predictive Modeling Capabilities 1365.9.3 Challenges and Opportunities in the Future of Predictive Modeling in Pharmaceutical Research 1375.10 Conclusion 1385.10.1 Drug Development 1385.10.1.1 Improved Drug Discovery 1395.10.1.2 Personalized Medicine 1395.10.1.3 Integration of Multi-Omics Data 1395.10.1.4 Enhanced AI Algorithms 1395.10.1.5 Big Data Analytics 1395.10.1.6 Collaborative Research Efforts 139References 1396 Adverse Impact of Human Data Science in Pharmacovigilance (HDS-PV) and Their Potential Applications 151B. Prabadevi, M. Pradeepa, S. Sudhagara Rajan and S. Kumaraperumal6.1 Introduction 1526.2 Pharmacovigilance 1536.2.1 Introduction to Pharmacovigilance 1536.2.2 Phases in Pharmacovigilance 1546.3 Human Data Science in Pharmacovigilance 1576.3.1 Human Data Science 1576.3.2 Data for Human Data Science in Pharmacovigilance (hds-pv) 1576.3.3 Medical Data for Pharmacovigilance 1586.3.4 Techniques in Human Data Science 1626.3.4.1 Data Mining 1626.3.4.2 Disproportionality 1636.3.4.3 Change-Point Analysis (CPA) 1636.3.4.4 Geographical Information Systems (GIS) 1646.3.4.5 Natural Language Processing and Its Application 1646.3.4.6 Artificial Intelligence Methodologies 1656.3.4.7 Data Visualization 1666.4 Challenges in the Amalgamation of Human Data Science and Pharmacovigilance 1696.4.1 Potential Risks in Pharmacovigilance 1696.4.2 Data Challenges in HDS-PV 1706.4.3 Various Errors in the Process 1726.4.4 Legal Issues and Concerns 1726.4.5 Other Challenges 1736.5 Future Research Prospects 1736.5.1 Federated Learning for Pharmacovigilance 1736.5.2 Explainable AI to Avoid Transparency Issues 1746.5.3 Blockchain for Enhanced Security 1746.5.4 6G and Beyond for Pharmacovigilance 1756.6 Conclusion 175References 1767 Data Science for Product Lifecycle Management 181Bhagyashree N. Singh, Shivani Gandhi and Nisha ParikhAbbreviation 1827.1 Introduction 1827.1.1 The Beginner’s Guide to Product Lifecycle Management 1837.1.2 Alliteration Techniques in Data Science of Product Lifecycle Management 1857.2 Role of Data Science in Preclinical Trial Studies for Product Lifecycle Management 1877.2.1 Clinical Trial Organizations Significantly Improving Pharmaceutical Manufacturing 1907.2.1.1 Enhancing Efficiency with the Internet of Things (IoT) in Pharma 1907.2.1.2 Integrating the Internet of Things in Pharmaceutical Manufacturing 1917.2.1.3 Techniques for Integrating the Internet of Things in Waste Management Systems 1917.3 Exploring Data Science Applications in Active Ingredient Management 1917.3.1 Data Science: A Catalyst for Advancement in Protein Design 1937.3.1.1 Assessing Risks of AI-Designed Protein 1937.3.2 Role of Artificial Intelligence/Machine Learning in Modern Pharmacology 1957.4 Machine Learning Algorithms for Toxicity Prediction 1967.4.1 Machine Learning Tools Used in Drug Development 1997.5 Redefining R&D Efficiency in Pharma through Data Science 2027.6 Intersection of Data Science and Pharmacovigilance 2027.6.1 The Challenges of Data Science in Pharmacovigilance 2037.7 Ways to Enhance Product Lifecycle Management Stability in Data Science 2047.7.1 Data Science Improving Quality Management System 2057.7.2 Impactful Data Science Trends in the Pharmaceutical Industry 2057.7.3 Utilization of Data Science in Pharma Regulations 2067.8 Optimizing Product Lifecycle with Data Science 2077.9 Conclusion 208References 2098 Data Science for Quality Management 217Dixa A. Vaghela, Amit Z. Chaudhari, Pankti C. Balar, Anup Kumar, Hetvi Solanki and Vivek P. Chavda8.1 Introduction 2188.2 Literature Review 2208.2.1 Historical Context of Quality Management 2208.2.2 Evolution of Data Science 2218.2.3 Integration of Data Science in Quality Management 2238.2.3.1 Data Quality Management 2238.2.3.2 Process Monitoring and Control 2248.2.3.3 Root Cause Analysis 2248.2.3.4 Optimization and Design of Experiments 2248.2.4 Key Theories and Frameworks 2258.2.4.1 Total Data Quality Management (TDQM) 2258.2.4.2 Six Sigma 2258.3 Data Quality Dimension 2268.3.1 Definition of Data Quality Dimensions 2268.3.2 Key Dimensions of Data Quality 2278.3.2.1 Timeliness 2278.3.3 Measuring Data Quality 2278.4 Data Quality Management 2288.4.1 Overview of Data Quality Frameworks 2288.4.2 Components of a Data Quality Framework 2298.4.2.1 Data Profiling and Assessment 2308.4.2.2 Data Governance and Stewardship 2318.4.2.3 Data Cleansing and Enrichment 2318.4.2.4 Continuous Monitoring and Improvement 2328.4.3 Common Data Quality Frameworks 2338.4.3.1 Dama Dmbok 2338.4.3.2 Cobit 2348.4.3.3 Itil 2358.5 Challenges and Barriers 2368.5.1 Common Challenges in Data Quality Management 2368.5.1.1 Data Accuracy and Integrity 2368.5.1.2 Completeness of Data 2368.5.1.3 Data Consistency Across Platforms 2378.5.1.4 Timeliness of Data 2378.5.1.5 Relevance to Quality Management Goals 2378.5.2 Barriers to Implementing Data Science in Quality Management 2378.5.2.1 Technological Barriers 2378.5.2.2 Organizational Resistance to Change 2398.5.2.3 Skills Gap in the Workforce 2398.5.2.4 Data Privacy and Security Concerns 2398.5.2.5 Financial Constraints 2398.5.3 Strategies to Overcome Challenges 2418.5.3.1 Investing in Scalable Technological Infrastructure 2418.5.3.2 Promoting Organizational Change and Cultivating a Data-Driven Culture 2428.5.3.3 Addressing the Skills Gap and Enhancing Workforce Readiness 2428.5.3.4 Ensuring Data Privacy and Security Compliance 2438.5.3.5 Implementing Cost-Effective Solutions for SMEs 2448.6 Future Directions 2458.6.1 Emerging Trends in Data Science and Quality Management 2458.6.1.1 Big Data Analytics 2458.6.1.2 Predictive and Prescriptive Analytics 2458.6.1.3 Cloud-Based Quality Management Systems (qms) 2468.6.1.4 Advanced Data Visualization 2468.6.2 The Role of Artificial Intelligence 2468.6.2.1 AI-Powered Quality Control 2468.6.2.2 Predictive Maintenance with AI 2478.6.2.3 AI in Customer Feedback Analysis 2478.6.2.4 AI for Continuous Improvement 2478.7 Conclusion 247References 2499 Data Science for Validation 259Shiwali Sharma, Narinderpal Kaur, Gagandeep Kaur and Parul Sood9.1 Introduction 2609.1.1 Overview of Validation in Data Science 2619.1.2 Definition of Validation 2629.1.3 Types of Validation 2629.1.4 Accepting and Relating the Types of Validation 2629.2 Importance of Validation 2639.2.1 Why Validation is Crucial for Data Science Projects 2639.2.2 Risks and Consequences of Neglecting Validation 2639.2.2.1 Inaccurate Predictions 2649.2.3 Addressing the Risks — Strategies for Effective Validation 2649.2.4 Validation as an Iterative Process 2659.3 Data Validation 2669.3.1 Methods for Validating Data Quality and Integrity 2669.3.1.1 Addressing Common Issues in Data Validation 2679.3.2 Model Validation 2679.3.2.1 Techniques for Validating Predictive Models 2679.3.3 Process Validation 2689.3.3.1 Importance of Validating Data Processing Pipelines 2689.4 Validation Techniques and Tools 2689.4.1 Statistical Methods 2689.4.2 Machine Learning Techniques 2709.4.3 Validation Tools 2709.5 Challenges in Data Science Validation 2719.5.1 Data Challenges 2719.5.2 Model Challenges 2729.5.3 Addressing Data and Model Challenges 2739.6 Case Studies 2749.6.1 Case Study: Manufacturing Predictive Maintenance 2749.6.2 Case Study: Fraud Detection in Financial Transactions 2759.7 Future Trends in Data Science Validation 2769.7.1 Emerging Trends and Technologies 2769.7.2 Role of AI and Automation in Improving Validation Processes 2789.8 Conclusion 279References 279Part 3: Advanced Topics and Future Prospects 28510 Data Science and Classification of Medical Data for Pharmacovigilance 287Rutvi Vaidya, Bhavin Vyas, Shrikant Joshi, Sonia Singh, Dhwani Desai and Preeti Bhatt10.1 Introduction to Data Science 28710.2 Data Processing 28910.2.1 Data Gathering 28910.2.2 Data Cleaning 28910.2.3 Data Integration 28910.2.4 Data Transformation 29010.2.5 Data Storage 29010.2.6 Data Analysis 29010.2.7 Data Visualization 29010.3 Types of Healthcare Data 29110.3.1 Clinical Data 29110.3.2 Administrative Data 29210.3.3 Financial Data 29210.3.4 Patient-Generated Data (PGD) 29310.3.5 Public Health Data 29310.3.6 Claims Data 29310.3.7 Data from Wearable Devices 29310.4 Classification of Medical Data Using Data Science 29410.4.1 The Importance of Medical Data Classification 29410.4.2 Challenges in Medical Data Classification 29410.4.3 Data Mining Techniques for Medical Data Classification 29510.4.4 Machine Learning Approaches 29610.4.5 Case Studies in Medical Data Classification 29710.4.6 Future Directions in Medical Data Classification 29710.5 Role and Significance of Data Science in Pharmacovigilance 29810.5.1 What is Data Science? 29810.5.2 What is Pharmacovigilance? 29810.5.3 Search Strategy 29910.5.4 Various Applications of Data Science 29910.6 Data Processing Algorithms — AI, ML, and dl 30010.6.1 AI and ML Algorithms for Pharmacovigilance 30010.6.2 Challenges and Considerations in Adopting AI/ML for Pharmacovigilance 30010.6.3 The Future of Pharmacovigilance with AI/ML 30110.6.4 Advancements in Deep Learning for Pharmacovigilance 30110.6.5 Challenges and Limitations for Deep Learning in Pharmacovigilance 30210.7 Predictive Models for Adverse Drug Reaction Detection 30310.7.1 Introduction to Pharmacovigilance and Its Importance in Healthcare Analytics 30310.7.2 Predictive Models in Pharmacovigilance: From Logistic Regression to Neural Networks 30410.7.3 Challenges and Future Directions in Predictive Modeling for Pharmacovigilance 30510.7.4 Key Insights and Perspectives of Predictive Model in Pharmacovigilance 30610.8 Application in Regulatory Attainment 30610.9 Availability of Open-Source Tools 30710.9.1 Introduction 30710.9.2 Data Collection and Management 30810.9.3 Data Integration and Interoperability 31510.9.4 Data Repositories and Ontologies 32010.10 Future Prospects and Ethical Considerations 32810.11 Conclusion 329References 33011 Data Science for Analytical Development and Quality Control 337Kunjan Bodiwala, Rahul Lalwani, Zalak Jain and Anuradha Gajjar11.1 Introduction 33711.2 Importance of Analytical Development and Quality Control in Pharmaceutical Industry 34011.3 Digitalization and Data Science in Pharma 4.0 34511.4 Data Science Tools for Process Development 34711.4.1 Process Understanding 34711.4.2 Product Understanding 34811.4.3 Key Tools Relevant to Process Development 34811.4.4 Specific Tools Relevant to the Analytical Development Stage 35011.5 Role of Data Science in Analytical Development and Quality Control 35211.5.1 Applications of Data Science in Analytical Laboratories 35511.5.1.1 Automation and Efficiency 35511.5.1.2 Sample Preparation and Analysis 35511.5.1.3 Data Management and Laboratory Information Management Systems (lims) 35611.5.1.4 Quality Assurance and Monitoring 35611.5.1.5 Statistical Process Control (SPC) 35611.5.1.6 Predictive Analytics and Risk Mitigation 35611.5.1.7 Machine Learning for Method Optimization 35711.5.1.8 Algorithmic Approaches to Method Development 35711.5.1.9 Predictive Modeling for Method Validation 35811.5.1.10 Real-Time Data Visualization 35811.5.1.11 Interactive Dashboards and Key Performance Indicators (KPIs) 35811.5.1.12 Collaborative Data Sharing 35811.5.2 Case Studies in Data Science Integration 35911.6 Applications of Data Science in Quality Control 36111.6.1 Predictive Models for Drug Development 36211.6.2 Application of Machine Learning 36211.6.3 Forecasting Patient Flow and Demand 36211.6.4 Time Series Analysis and Demand Forecasting 36311.6.5 Integrating External Factors 36311.6.6 Real-Time Analysis and Process Verification 36311.6.7 Implementing Advanced Sensors and IoT 36411.6.8 Benefits of Real-Time Analysis 36411.6.9 Statistical Quality Control and Process Monitoring 36411.6.10 Control Charts and Process Capability Analysis 36411.6.11 Data Science Enhancements 36511.6.12 Continued Process Verification (CPV) Using Data Science 36511.6.13 Implementing a CPV Framework 36511.6.14 Risk Assessment and Mitigation 36511.6.15 Improving Process Robustness 36611.6.16 Designing Robust Processes 36611.6.17 Continuous Learning and Adaptation 36611.6.18 Case Studies 36611.7 Challenges and Solutions 36911.8 Future Directions and Trends 374Bibliography 376Index 385